Exact Sciences Corporation (EXAS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Exact Sciences Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Exact Sciences Corporation (EXAS) has returned 3.30% so far this year and 142.34% over the past 12 months. Looking at the last ten years, EXAS has achieved an annualized return of 32.78%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Feb 1, 2001, EXAS's average daily return is +0.13%, while the average monthly return is +2.63%. At this rate, your investment would double in approximately 2.2 years.

Historically, 49% of months were positive and 51% were negative. The best month was Jan 2009 with a return of +161.4%, while the worst month was Oct 2015 at -53.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, EXAS closed higher 49% of trading days. The best single day was Jan 10, 2006 with a return of +53.7%, while the worst single day was Oct 6, 2015 at -46.1%.

Exact Sciences Corporation has an annualized alpha of 28.00%, beta of 0.90, and R² of 0.06 versus S&P 500 Index. Calculated based on daily prices since February 02, 2001.

• This stock captured 174.77% of S&P 500 Index gains and 145.40% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.06 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

EXAS ranks 95 for risk / return — in the top 95% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Exact Sciences Corporation (EXAS) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Exact Sciences Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Exact Sciences Corporation was 98.01%, occurring on Nov 24, 2008. Recovery took 1438 trading sessions.

The current Exact Sciences Corporation drawdown is 32.32%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Exact Sciences Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Exact Sciences Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.